This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2c67

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2c67.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2c67.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2c67| PDB=2c67 | SCENE= }}
{{STRUCTURE_2c67| PDB=2c67 | SCENE= }}
-
'''MAO INHIBITION BY RASAGILINE ANALOGUES'''
+
===MAO INHIBITION BY RASAGILINE ANALOGUES===
-
==Overview==
+
<!--
-
Monoamine oxidases A and B (MAO A and B) catalyze the degradation of neurotransmitters and represent drug targets for the treatment of neurodegenerative disorders. Rasagiline is an irreversible, MAO B-selective inhibitor that has been approved as a novel anti-Parkinson's drug. In this study, we investigate the inhibition of recombinant human MAO A and MAO B by several rasagiline analogues. Different substituents added onto the rasagiline scaffold alter the binding affinity depending on the position on the aminoindan ring and on the size of the substituent. Compounds with a hydroxyl group on either the C4 or the C6 atom inhibit both isozymes, whereas a bulkier substituent such as a carbamate is tolerated only at the C4 position. The 1.7 A crystal structure of MAO B in complex with 4-(N-methyl-N-ethyl-carbamoyloxy)-N-methyl-N-propargyl-1(R)-aminoindan shows that the binding mode is similar to that of rasagiline with the carbamate moiety occupying the entrance cavity space. 1(R)-Aminoindan, the major metabolic product of rasagiline, and its analogues reversibly inhibit both MAO A and MAO B. The crystal structure of N-methyl-1(R)-aminoindan bound to MAO B shows that its aminoindan ring adopts a different orientation compared to that of rasagiline.
+
The line below this paragraph, {{ABSTRACT_PUBMED_16366596}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 16366596 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_16366596}}
==About this Structure==
==About this Structure==
Line 40: Line 44:
[[Category: Rasagiline]]
[[Category: Rasagiline]]
[[Category: Transmembrane]]
[[Category: Transmembrane]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 21:19:09 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 02:38:09 2008''

Revision as of 23:38, 27 July 2008

Image:2c67.png

Template:STRUCTURE 2c67

MAO INHIBITION BY RASAGILINE ANALOGUES

Template:ABSTRACT PUBMED 16366596

About this Structure

2C67 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Binding of rasagiline-related inhibitors to human monoamine oxidases: a kinetic and crystallographic analysis., Binda C, Hubalek F, Li M, Herzig Y, Sterling J, Edmondson DE, Mattevi A, J Med Chem. 2005 Dec 29;48(26):8148-54. PMID:16366596

Page seeded by OCA on Mon Jul 28 02:38:09 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2c67"
Personal tools